NCT00005823View on ClinicalTrials.gov

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

December 31, 1998

Study Completion Date

December 31, 2007

Conditions

LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

etoposide

DRUG

hydroxyurea

DRUG

idarubicin

DRUG

mitoxantrone hydrochloride

DRUG

thioguanine

DRUG

tretinoin

DRUG

valspodar

Trial Locations (3)

B15 2RR

Queen Elizabeth Hospital at University of Birmingham, Birmingham

WC1E 6AU

University College Hospital, London

CF14 4XN

University Hospital of Wales, Cardiff

All Listed Sponsors

lead

Leukemia Research Fund

OTHER

NCT00005823 - Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter